Our characterization of this hotspot mutation, leveraging primary human keratinocytes and the Ras-CDK4 cSCC model, demonstrates that the SRCAP-1879 truncation is sufficient to dysregulate gene expression in a cell-state-dependent manner and promote cancer invasion with the induction of MMP9. Here, CDK4 is linked to cancer.